The Funded: Denali Therapeutics sets IPO price range; 4 others raise rounds

South San Francisco-based Denali Therapeutics hopes to raise up to $182 million in an IPO it plans for a week from Friday. Here's more about that and several Bay Area fundings that were disclosed at midweek.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.